Back

Title
  • Direction for Basal Insulin Therapy by Once Daily Injection in the Clinical Practice
Creator
    • Bando, Hiroshi
Rights
  • This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Subject
  • Other American Diabetes Association (ADA)
  • Other Dual Action of Liraglutide and Insulin Degludec (DUAL) studies
  • Other Xultophy
  • Other Multiple Daily Injection (MDI)
  • Other Once Daily Injection
Description
  • Other American Diabetes Association (ADA) has announced the new version of the standards of Medical Care in Diabetes-2021. The guideline of the diabetic patients with Older Adults seems to be used for a wide range of clinical practice. Among them, several impressive comments were found, where “Once-daily basal insulin injection therapy is associated with minimal side effects and maybe a reasonable option in many elder patients”. Recent topic includes Dual Action of Liraglutide and insulin degludec (DUAL) studies, and Xultophy has shown beneficial efficacy. Consequently, the trend would be developed from multiple daily injection (MDI) method to once daily injection.
Publisher Asploro
Date
    Issued2021-02-17
Language
  • eng
Resource Type journal article
Version Type VoR
Identifier URI http://repo.lib.tokushima-u.ac.jp/115863
Relation
  • isIdenticalTo DOI https://doi.org/10.36502/2021/droa.6177
Journal
  • Diabetes Research : Open Access
  • Volume Number3 Issue Number1 Page Start11 Page End15
File
Oaidate 2023-06-26